Square Pharmaceuticals PLC. (DSE: SQURPHARMA)

SQURPHARMA Market Cap

SQURPHARMA has a market cap or net worth of 199.10 billion as of October 16, 2024. Its market cap has increased by 6.60% in one year.

• Market Cap: 199.10B
• Enterprise Value: 142.93B
• Revenue: 68.81B
• Ranking: n/a
• PE Ratio: 9.84
• Stock Price: 224.60

Market Cap Chart

Since April 18, 2002, SQURPHARMA's market cap has increased from 3.10B to 199.10B, an increase of 6,317.31%. That is a compound annual growth rate of 20.31%.

Market Cap History

Date	Market Cap	% Change
Oct 15, 2024	199.10B	6.80%
Dec 28, 2023	186.42B	0.24%
Dec 29, 2022	185.98B	-2.10%
Dec 30, 2021	189.97B	-2.37%
Dec 30, 2020	194.58B	21.30%
Dec 30, 2019	160.41B	-20.02%